Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010
Wed, October 27, 2010
Tue, October 26, 2010
Mon, October 25, 2010
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ] - Market Wire
Alcon Board Elects New Chairman
Sat, October 23, 2010
Fri, October 22, 2010
Thu, October 21, 2010
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
STJ, AGAM, BAC, MDT, BSX
Tue, October 19, 2010
Mon, October 18, 2010
Sun, October 17, 2010
Sat, October 16, 2010
Fri, October 15, 2010
[ Fri, Oct 15th 2010 ] - Market Wire
ALGN, FCN, GOOG, SWY, GCI
Thu, October 14, 2010
Wed, October 13, 2010

AngioDynamics to Participate at the 21st Annual Oppenheimer Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. st-annual-oppenheimer-healthcare-conference.html
Published in Health and Fitness on Monday, October 25th 2010 at 3:41 GMT by Market Wire   Print publication without navigation


ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the 21st Annual Oppenheimer Healthcare Conference at 4:30 p.m. ET on Wednesday, November 3, 2010, at The Waldorf-Astoria Hotel in New York. Joseph Gersuk, Executive Vice President and Chief Financial Officer of AngioDynamics, will review the Companya™s business strategy and recent corporate developments.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Companya™s Web site at: [ http://investors.angiodynamics.com ]. The archived presentation will be available for 90 days.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamicsa™ diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].


Publication Contributing Sources